Cite

HARVARD Citation

    Planchard, D. et al. (n.d.). 3081 Molecular Tumor Board (MTB) in non-small cell lung cancers (NSCLC) to optimize targeted therapies: 4 years' experience at Gustave Roussy. European journal of cancer. pp. S624-. [Online]. 
  
Back to record